Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.

@article{Estep2015RiskAA,
  title={Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.},
  author={Jerry D. Estep and Randall C. Starling and Douglas A Horstmanshof and Carmelo A. Milano and Craig H. Selzman and Keyur Bharat Shah and Matthias M Loebe and Nader Moazami and James W Long and Josef Stehlik and Vigneshwar Kasirajan and Donald C Haas and John B O'connell and A. R. Boyle and David Mascarenas Donald Hush James Theiler Charles Farrar and J. G. Rogers},
  journal={Journal of the American College of Cardiology},
  year={2015},
  volume={66 16},
  pages={1747-1761}
}
BACKGROUND Data for left ventricular assist devices (LVADs) in patients with noninotrope-dependent heart failure (HF) are limited. OBJECTIVES The goal of this study was to evaluate HeartMate II (HMII) LVAD support versus optimal medical management (OMM) in ambulatory New York Heart Association functional class IIIB/IV patients meeting indications for LVAD destination therapy but not dependent on intravenous inotropic support. METHODS This was a prospective, multicenter (N = 41… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 10 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 66 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

INTERMACS Profiling Identifies Risk of Death or VAD among Medically-Managed Advanced Heart Failure Patients

  • GC Stewart, JJ Teuteberg, M Kittleson
  • Paper presented at: ISHLT 33rd Annual Meeting…
  • 2013
3 Excerpts

Similar Papers

Loading similar papers…